Gil Leibowitz
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Nephrology top 5%
Papers in
-
- Diabetes Treatment and Management 13
- Diabetes Management and Research 11
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 6
- Surgery 23
- Pancreatic function and diabetes 21
- Co-authors
- Fred LevineErol CerasiMarc Y. DonathDerek LeRoithRena PollackTanya HalvorsenE CerasiBenjamin Gläser
- Journals
- Diabetes Obesity and Metabolism (6 papers)Diabetes (4 papers)Diabetes Care (4 papers)Cell Reports (2 papers)Journal of Internal Medicine (2 papers)
- Partner nations
- IsraelUnited StatesSweden
In The Last Decade
Gil Leibowitz
44 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Endocrinology, Diabetes and Metabolism 732
- Nephrology 112
- Surgery 657
- Genetics 342
- Aging 19
Countries citing papers authored by Gil Leibowitz
This map shows the geographic impact of Gil Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Leibowitz more than expected).
Fields of papers citing papers by Gil Leibowitz
This network shows the impact of papers produced by Gil Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Leibowitz. The network helps show where Gil Leibowitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gil Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 5 | |
| 10 | 2020 | 93 | |
| 11 | 2018 | 44 | |
| 12 | 2016 | 45 | |
| 13 | 2015 | 21 | |
| 14 | 2011 | 63 | |
| 15 | 2011 | 58 | |
| 16 | 1996 | 11 | |
| 17 | 1996 | 80 | |
| 18 | 1994 | 18 | |
| 19 | 1993 | 5 | |
| 20 | 1990 | 2 |
About Gil Leibowitz
Gil Leibowitz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Nephrology and Cell Biology, having authored 48 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (21 papers), Diabetes Treatment and Management (13 papers), Diabetes Management and Research (11 papers), Diabetes and associated disorders (9 papers), Metabolism, Diabetes, and Cancer (9 papers), Endoplasmic Reticulum Stress and Disease (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diet and metabolism studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (732 citations), Nephrology (112 citations), Surgery (657 citations), Genetics (342 citations) and Aging (19 citations). Gil Leibowitz has collaborated with scholars based in Israel, United States and Sweden. Frequent co-authors include Fred Levine, Erol Cerasi, Marc Y. Donath, Derek LeRoith, Rena Pollack, Tanya Halvorsen, E Cerasi, Benjamin Gläser, Nurit Kaiser and Itamar Raz. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Diabetes Care, Cell Reports and Journal of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.